Association between renin–angiotensin system inhibitors and COVID-19 complications
Association between renin–angiotensin system inhibitors and COVID-19 complications
About this item
Full title
Author / Creator
Publisher
England: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
England: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Abstract
Aims
To describe the characteristics of patients hospitalized with COVID-19 (including their long-term at-home medication use), and compare them with regard to the course of the disease. To assess the association between renin–angiotensin system inhibitors (RASIs) and disease progression and critical outcomes.
Methods and results<...
Alternative Titles
Full title
Association between renin–angiotensin system inhibitors and COVID-19 complications
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7314068
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7314068
Other Identifiers
ISSN
2055-6837,2055-6845
E-ISSN
2055-6845
DOI
10.1093/ehjcvp/pvaa062
